PTSM: Pharmaceutical Technology Sourcing and Management-03-02-2016

Scale-down modeling accelerates the development of downstream biopharma manufacturing processes.

Analytical laboratory equipment adapts for new realities of downsizing, outsourcing, and speed demands.

Global economic and political uncertainty could slow bio/pharma development activity.

Hazardous reagents can prove to be faster, simpler, cheaper, and greener.

The Tacta range of pipettes handle a range of volumes and liquids.

The Medifuge small benchtop centrifuge from Thermo Scientific provides versatility within a compact footprint.

Cirrus Pharmaceuticals will launch services for manufacturing cGMP materials for early-phase clinical trials at its Raleigh-Durham, NC facility.

ICIG’s CordenPharma Group expands fermentation-based production technology with acquisition of Sandoz Site.

Recipharm acquires Mitim, adding scale and technology in injectable beta lactams.

Patheon will assist in the development of INTAC, a technology designed to reduce the abuse of controlled substances.

AAIPharma/Cambridge Major Labs plans to invest $10.7 million to relocate the company’s analytical testing facility to the Cortex Innovation Center in Missouri.

PharmSource report addresses how the opportunity for antibody drug conjugates measures up to the bio/pharma industry’s expectations.

3M Drug Delivery Systems, Ei Solutionworks, IDT Biologika join CMO/CDMO association

The agency prepares a plan to implement new packaging safety features.